production routes that afford radionuclidic purity suitable for clinical application require costly enriched targets or access to nuclear reactors with significant high energy neutron flux (En > 1 MeV). Therefore, the poor availability of47Sc, due to the above requirements, has hampered preclini...
needed in the treatment in mice as reported [20], which may require time-consuming conditioned media collection and cell expansion and thus limit its large-scale application [19]. Furthermore, the time-consuming and complicated purification process severely limits the amount of MSC-EVs that may b...
They have the same chemical properties and pharmacokinetics that help in the efficient planning and monitoring of personalized targeted cancer treatment [2]. With the use of “matched pair” radiopharmaceuticals, the received-dose estimation and pharmacokinetics in the body could better be understood ...
They have the same chemical properties and pharmacokinetics that help in the efficient planning and monitoring of personalized targeted cancer treatment [2]. With the use of “matched pair” radiopharmaceuticals, the received-dose estimation and pharmacokinetics in the body could better be understood ...